XML 50 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Equity (Details Narrative) - EUR (€)
€ / shares in Units, € in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Feb. 25, 2021
Jun. 30, 2022
Jun. 30, 2022
Other income (Details Narrative)      
Description of common shares Sales Agreement     the Company filed a Form F-3 (Registration Statement) with the United States Securities and Exchange Commission (SEC) with respect to the offer and sale of securities of the Company. The Company also filed a prospectus supplement (Prospectus Supplement) with the SEC relating to an at-the-market program providing for the sale of up to $50.0 million of its common shares over time pursuant to a Sales Agreement with SVB Leerink LLC
Remaining value authorized for sale under the Sales Agreement   € 35,200 € 35,200
Sold common shares through a public offering 15,000,000    
Sold at a price € 5.00    
Warrant to purchase a common share at an exercise price 5.80    
Nominal value € 0.12    
Gross offering proceeds € 3,700    
Underwriting discounts 400    
Other offering expenses € 300 € 15 € 30